Said Saim
Chief Tech/Sci/R&D Officer presso EYEPOINT PHARMACEUTICALS, INC.
Profilo
Said Saim is currently working as the Chief Technology Officer & Senior VP at EyePoint Pharmaceuticals, Inc. Prior to his current position, he worked as the Senior Director-Pharmaceutical Development at Collegium Pharmaceutical, Inc. from 2008 to 2013.
He also held the position of Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc. and Assistant Research Professor at Higuchi Bioscience Center.
Dr. Saim completed his graduate and doctorate degrees at the University of Kansas.
Posizioni attive di Said Saim
Società | Posizione | Inizio |
---|---|---|
EYEPOINT PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10/06/2019 |
Precedenti posizioni note di Said Saim
Società | Posizione | Fine |
---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Higuchi Bioscience Center | Corporate Officer/Principal | - |
COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - |
Formazione di Said Saim
University of Kansas | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Higuchi Bioscience Center |
- Borsa valori
- Insiders
- Said Saim